Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benaglutide pump plus insulin pump versus insulin pump alone in newly diagnosed type 2 diabetes
ChiCTR1800015914Phase 4Recruiting
- Sponsor
- Nanjing First Hospital
- Start
- May 2018
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of beinaglutide and human insulin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Nanjing First Hospital. Primary endpoints: Oral glucose tolerance test and Islet alpha-cell function. Started May 2018; status: recruiting.
02
Drugs
beinaglutidehuman insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR1800015914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015914.